Centene Co. (NYSE:CNC) Shares Purchased by Everpar Advisors LLC

Everpar Advisors LLC grew its position in shares of Centene Co. (NYSE:CNC) by 51.5% in the 4th quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 7,621 shares of the company’s stock after acquiring an additional 2,590 shares during the quarter. Everpar Advisors LLC’s holdings in Centene were worth $462,000 at the end of the most recent quarter.

Several other hedge funds and other institutional investors have also modified their holdings of the company. Assenagon Asset Management S.A. increased its position in shares of Centene by 693.5% in the fourth quarter. Assenagon Asset Management S.A. now owns 1,705,936 shares of the company’s stock worth $103,346,000 after acquiring an additional 1,490,935 shares in the last quarter. Harris Associates L P increased its holdings in Centene by 5.7% in the 3rd quarter. Harris Associates L P now owns 26,314,183 shares of the company’s stock valued at $1,980,932,000 after purchasing an additional 1,420,825 shares in the last quarter. AQR Capital Management LLC lifted its stake in shares of Centene by 22.9% during the second quarter. AQR Capital Management LLC now owns 4,461,517 shares of the company’s stock worth $295,799,000 after purchasing an additional 832,318 shares in the last quarter. Legal & General Group Plc grew its stake in shares of Centene by 14.2% in the second quarter. Legal & General Group Plc now owns 5,113,759 shares of the company’s stock valued at $339,042,000 after buying an additional 636,683 shares in the last quarter. Finally, Hotchkis & Wiley Capital Management LLC raised its holdings in shares of Centene by 15.4% during the 3rd quarter. Hotchkis & Wiley Capital Management LLC now owns 3,203,049 shares of the company’s stock valued at $241,126,000 after buying an additional 428,100 shares during the period. 93.63% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In other Centene news, Director Thomas Greco purchased 17,000 shares of the business’s stock in a transaction dated Wednesday, December 18th. The shares were bought at an average price of $59.75 per share, with a total value of $1,015,750.00. Following the completion of the acquisition, the director now owns 19,309 shares in the company, valued at approximately $1,153,712.75. This represents a 736.25 % increase in their position. The acquisition was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through the SEC website. Also, CFO Andrew Lynn Asher acquired 17,200 shares of the firm’s stock in a transaction that occurred on Wednesday, November 13th. The stock was acquired at an average cost of $58.14 per share, with a total value of $1,000,008.00. Following the completion of the acquisition, the chief financial officer now directly owns 486,847 shares in the company, valued at approximately $28,305,284.58. This represents a 3.66 % increase in their ownership of the stock. The disclosure for this purchase can be found here. Insiders have acquired 45,010 shares of company stock valued at $2,660,276 over the last quarter. Insiders own 0.29% of the company’s stock.

Analyst Ratings Changes

A number of research firms have recently issued reports on CNC. StockNews.com lowered shares of Centene from a “strong-buy” rating to a “buy” rating in a research note on Monday, October 28th. UBS Group raised shares of Centene from a “neutral” rating to a “buy” rating and lifted their price target for the stock from $79.00 to $80.00 in a research note on Friday, December 13th. Jefferies Financial Group downgraded Centene from a “hold” rating to an “underperform” rating and lowered their target price for the company from $68.00 to $52.00 in a research note on Tuesday, December 10th. JPMorgan Chase & Co. reiterated an “overweight” rating and issued a $75.00 price target (down previously from $80.00) on shares of Centene in a research note on Tuesday, December 17th. Finally, Wells Fargo & Company dropped their price objective on Centene from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Monday, November 4th. One equities research analyst has rated the stock with a sell rating, four have given a hold rating and ten have issued a buy rating to the company’s stock. Based on data from MarketBeat, the company has a consensus rating of “Moderate Buy” and a consensus price target of $80.92.

Centene Trading Down 0.5 %

Centene stock opened at $62.86 on Friday. The company has a debt-to-equity ratio of 0.64, a quick ratio of 1.10 and a current ratio of 1.10. Centene Co. has a 1 year low of $55.03 and a 1 year high of $81.42. The firm’s 50-day moving average is $60.07 and its 200-day moving average is $67.38. The company has a market cap of $31.74 billion, a P/E ratio of 10.91, a PEG ratio of 0.83 and a beta of 0.45.

Centene Company Profile

Centene Corporation operates as a healthcare enterprise that provides programs and services to under-insured and uninsured families, commercial organizations, and military families in the United States. The company operates through Medicaid, Medicare, Commercial, and Other segments. The Medicaid segment offers health plan coverage, including medicaid expansion, aged, blind, disabled, children’s health insurance program, foster care, medicare-medicaid plans, long-term services and support.